| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Thursday, December 23, 2021 11:25:31 AM
Deep6....
No doubt the chart looks nasty...But it is what is behind the chart that is of importance...Low prices offer "asymmetric bets" ..and asymmetric bets offer great rewards...Take the long tale of Amarin..Before the American Heart Association meeting in Nov. 2018. The PPs in the spring the stock PPS dropped to 80 cents. There was not a ton of optimism to say the least..
Because of my strong background in medicine and physiology. I knew the PPs was insane. I bought 100,000 shares for less than $90,000...After the meeting the price went up and was over $20 for several momths allowing me to cash in for over $1.5 Million...I did hold a portion of the stock and lost a substantial amount later on when Amarin lost the patent trial..
I do not see anything that that contradicts the notion the PPS of BNGO is ridiculous and I have some familiarity with the concepts the utility...I am a graduate of MIT and Harvard Med School...I am also a very long term investor in the stock market having made my first purchase *50 shares of Motorola in the 1950s when I was a teenager..
Best of luck...:">) JL
No doubt the chart looks nasty...But it is what is behind the chart that is of importance...Low prices offer "asymmetric bets" ..and asymmetric bets offer great rewards...Take the long tale of Amarin..Before the American Heart Association meeting in Nov. 2018. The PPs in the spring the stock PPS dropped to 80 cents. There was not a ton of optimism to say the least..
Because of my strong background in medicine and physiology. I knew the PPs was insane. I bought 100,000 shares for less than $90,000...After the meeting the price went up and was over $20 for several momths allowing me to cash in for over $1.5 Million...I did hold a portion of the stock and lost a substantial amount later on when Amarin lost the patent trial..
I do not see anything that that contradicts the notion the PPS of BNGO is ridiculous and I have some familiarity with the concepts the utility...I am a graduate of MIT and Harvard Med School...I am also a very long term investor in the stock market having made my first purchase *50 shares of Motorola in the 1950s when I was a teenager..
Best of luck...:">) JL
Recent BNGO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:09:36 PM
- Bionano Reports First Quarter 2026 Results and Provides a Business Update • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:03:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2026 08:02:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:30:53 PM
- Bionano Announces Leadership Transition • GlobeNewswire Inc. • 05/06/2026 08:30:00 PM
- Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:51 PM
- Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/25/2026 08:28:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:08:58 PM
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 • GlobeNewswire Inc. • 03/23/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:04:52 PM
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:29:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:26:55 PM
